Hedge Fund Group Gets Review Of Bowel Disease Drug Patent
After a recent string of setbacks at the Patent Trial and Appeal Board, a group with ties to hedge fund manager Kyle Bass convinced the board Thursday to institute an American...To view the full article, register now.
Already a subscriber? Click here to view full article